Share Price and Basic Stock Data
Last Updated: November 10, 2025, 8:00 pm
| PEG Ratio | 13.42 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Hindustan Unilever Ltd (HUL), a leader in the personal care sector, reported a share price of ₹2,497 and a market capitalization of ₹5,86,716 Cr. The company has shown consistent revenue growth, with sales increasing from ₹52,446 Cr in FY 2022 to ₹60,580 Cr in FY 2023, and further rising to ₹61,896 Cr in FY 2024. The trailing twelve months (TTM) sales stood at ₹63,928 Cr, indicating a robust sales trajectory. Quarterly sales figures reflect a steady performance, with Q1 FY 2025 reporting ₹15,670 Cr, an increase from ₹15,496 Cr in Q2 FY 2024. This upward trend underscores HUL’s strong market position, driven by its diverse product portfolio and brand equity. The company’s operational efficiency is highlighted by an operating profit margin (OPM) of 23% and a return on capital employed (ROCE) of 27.8%, showcasing effective cost management and resource utilization. Additionally, the cash conversion cycle remains efficient at -71 days, reflecting HUL’s ability to convert investments into cash flows swiftly, a significant advantage in the consumer goods sector.
Profitability and Efficiency Metrics
HUL demonstrated strong profitability metrics, with a net profit of ₹10,827 Cr for FY 2025, representing a 6.8% increase from ₹10,282 Cr in FY 2024. The earnings per share (EPS) rose to ₹45.32, reflecting HUL’s capacity to generate substantial returns for shareholders. The company achieved a robust return on equity (ROE) of 20.7%, indicating effective management of shareholder funds. Furthermore, the interest coverage ratio (ICR) stood at an impressive 40.17x, showcasing HUL’s strong ability to meet interest obligations. The operating profit margin remained stable around 23% to 24% over the reporting periods, reflecting consistent operational efficiency. However, the company faced rising expenses, which grew from ₹39,589 Cr in FY 2022 to ₹46,433 Cr in FY 2023, impacting overall profitability. Despite these challenges, HUL’s consistent dividend payout ratio of 116.94% for FY 2025 illustrates its commitment to returning capital to shareholders, enhancing investor confidence in its long-term profitability.
Balance Sheet Strength and Financial Ratios
HUL’s balance sheet remains robust, with total assets reported at ₹79,863 Cr for FY 2025, a slight increase from ₹78,489 Cr in FY 2024. The company maintains a healthy reserve of ₹49,167 Cr, which supports its operational needs and growth initiatives. Total borrowings stood at ₹1,648 Cr, indicating a low leverage ratio, which is crucial for maintaining financial stability. The company’s current ratio of 1.33 demonstrates adequate liquidity to cover short-term liabilities. Additionally, HUL’s price-to-book value (P/BV) ratio is reported at 10.75x, which is relatively high compared to typical sector ranges, suggesting that the stock is trading at a premium due to its strong fundamentals and brand reputation. The return on assets (ROA) remained at 13.33% for FY 2025, reflecting effective asset utilization. However, the company’s reliance on borrowings, while low, may pose risks in an increasing interest rate environment, potentially impacting future growth and profitability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Hindustan Unilever indicates strong promoter confidence, with promoters holding 61.90% of the total shares consistently across reporting periods. Foreign institutional investors (FIIs) have reduced their stake from 14.05% in September 2022 to 10.18% by March 2025, reflecting a cautious outlook amidst global economic uncertainties. Domestic institutional investors (DIIs), however, have increased their holdings from 11.72% to 15.99% over the same period, suggesting a growing confidence among local investors. The public shareholding stood at 11.86%, indicating a stable retail investor base. The total number of shareholders reported as of March 2025 was 11,67,945, reflecting a steady interest in HUL’s shares. This mix of shareholding patterns underscores a generally positive investor sentiment, despite some fluctuations in foreign investment, which could be attributed to global market conditions and competition in the consumer goods sector.
Outlook, Risks, and Final Insight
Looking ahead, Hindustan Unilever is well-positioned to leverage its extensive distribution network and brand strength to capitalize on growth opportunities in the personal care industry. However, challenges such as rising costs and increasing competition could impact profitability. The company’s ability to maintain its operating profit margin amidst these pressures will be critical. Additionally, potential fluctuations in consumer demand due to economic conditions could pose risks to revenue growth. HUL’s strong balance sheet and high return metrics provide a solid foundation for navigating these challenges. The company may also explore strategic acquisitions or product innovations to enhance its market position. Ultimately, while HUL faces certain risks, its established market presence, operational efficiency, and commitment to shareholder returns suggest a favorable long-term outlook for investors.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Hindustan Unilever Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Honasa Consumer Ltd | 8,959 Cr. | 275 | 388/190 | 126 | 36.9 | 0.00 % | 7.44 % | 5.51 % | 10.0 |
| Ambica Agarbathies Aroma & Industries Ltd | 44.8 Cr. | 26.1 | 37.0/23.3 | 87.8 | 63.6 | 0.00 % | 7.49 % | 0.45 % | 10.0 |
| Ador Multi Products Ltd | 102 Cr. | 107 | 119/23.4 | 19.4 | 0.00 % | 11.4 % | 3.09 % | 10.0 | |
| Kaya Ltd | 619 Cr. | 415 | 488/204 | 106 | 0.00 % | 2.50 % | % | 10.0 | |
| Jyothy Labs Ltd | 11,507 Cr. | 313 | 504/268 | 31.4 | 55.8 | 1.12 % | 24.6 % | 19.0 % | 1.00 |
| Industry Average | 66,233.27 Cr | 1,954.64 | 61.67 | 114.02 | 0.74% | 29.21% | 23.91% | 4.94 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 14,624 | 15,144 | 15,597 | 15,215 | 15,496 | 15,623 | 15,567 | 15,210 | 15,707 | 15,926 | 15,818 | 15,670 | 16,514 |
| Expenses | 11,222 | 11,665 | 11,903 | 11,643 | 11,832 | 11,828 | 11,902 | 11,675 | 11,965 | 12,139 | 12,123 | 12,052 | 12,797 |
| Operating Profit | 3,402 | 3,479 | 3,694 | 3,572 | 3,664 | 3,795 | 3,665 | 3,535 | 3,742 | 3,787 | 3,695 | 3,618 | 3,717 |
| OPM % | 23% | 23% | 24% | 23% | 24% | 24% | 24% | 23% | 24% | 24% | 23% | 23% | 23% |
| Other Income | 121 | 80 | 7 | 240 | 146 | 178 | 184 | 309 | 209 | 203 | 740 | 171 | 74 |
| Interest | 28 | 28 | 29 | 29 | 50 | 88 | 91 | 105 | 93 | 110 | 112 | 80 | 127 |
| Depreciation | 281 | 272 | 293 | 291 | 286 | 297 | 313 | 320 | 329 | 338 | 341 | 347 | 361 |
| Profit before tax | 3,214 | 3,259 | 3,379 | 3,492 | 3,474 | 3,588 | 3,445 | 3,419 | 3,529 | 3,542 | 3,982 | 3,362 | 3,303 |
| Tax % | 26% | 18% | 27% | 26% | 26% | 26% | 27% | 25% | 26% | 27% | 25% | 26% | 16% |
| Net Profit | 2,391 | 2,670 | 2,481 | 2,601 | 2,556 | 2,657 | 2,508 | 2,561 | 2,612 | 2,595 | 2,989 | 2,475 | 2,768 |
| EPS in Rs | 10.13 | 11.34 | 10.53 | 11.07 | 10.87 | 11.30 | 10.68 | 10.89 | 11.11 | 11.03 | 12.70 | 10.49 | 11.73 |
Last Updated: August 2, 2025, 1:20 am
Below is a detailed analysis of the quarterly data for Hindustan Unilever Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 16,514.00 Cr.. The value appears strong and on an upward trend. It has increased from 15,670.00 Cr. (Mar 2025) to 16,514.00 Cr., marking an increase of 844.00 Cr..
- For Expenses, as of Jun 2025, the value is 12,797.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 12,052.00 Cr. (Mar 2025) to 12,797.00 Cr., marking an increase of 745.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 3,717.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,618.00 Cr. (Mar 2025) to 3,717.00 Cr., marking an increase of 99.00 Cr..
- For OPM %, as of Jun 2025, the value is 23.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 23.00%.
- For Other Income, as of Jun 2025, the value is 74.00 Cr.. The value appears to be declining and may need further review. It has decreased from 171.00 Cr. (Mar 2025) to 74.00 Cr., marking a decrease of 97.00 Cr..
- For Interest, as of Jun 2025, the value is 127.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 80.00 Cr. (Mar 2025) to 127.00 Cr., marking an increase of 47.00 Cr..
- For Depreciation, as of Jun 2025, the value is 361.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 347.00 Cr. (Mar 2025) to 361.00 Cr., marking an increase of 14.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 3,303.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,362.00 Cr. (Mar 2025) to 3,303.00 Cr., marking a decrease of 59.00 Cr..
- For Tax %, as of Jun 2025, the value is 16.00%. The value appears to be improving (decreasing) as expected. It has decreased from 26.00% (Mar 2025) to 16.00%, marking a decrease of 10.00%.
- For Net Profit, as of Jun 2025, the value is 2,768.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,475.00 Cr. (Mar 2025) to 2,768.00 Cr., marking an increase of 293.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 11.73. The value appears strong and on an upward trend. It has increased from 10.49 (Mar 2025) to 11.73, marking an increase of 1.24.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 22, 2025, 4:15 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 29,234 | 31,972 | 32,186 | 33,162 | 35,545 | 39,310 | 39,783 | 47,028 | 52,446 | 60,580 | 61,896 | 63,121 | 63,928 |
| Expenses | 24,475 | 26,560 | 26,276 | 26,834 | 28,046 | 30,430 | 29,922 | 35,402 | 39,589 | 46,433 | 47,237 | 48,278 | 49,111 |
| Operating Profit | 4,759 | 5,412 | 5,910 | 6,328 | 7,499 | 8,880 | 9,861 | 11,626 | 12,857 | 14,147 | 14,659 | 14,843 | 14,817 |
| OPM % | 16% | 17% | 18% | 19% | 21% | 23% | 25% | 25% | 25% | 23% | 24% | 24% | 23% |
| Other Income | 792 | 1,247 | 486 | 606 | 353 | 322 | 424 | 170 | 219 | 448 | 817 | 1,322 | 1,188 |
| Interest | 41 | 18 | 17 | 35 | 26 | 33 | 118 | 117 | 106 | 114 | 334 | 395 | 429 |
| Depreciation | 296 | 322 | 353 | 432 | 520 | 565 | 1,002 | 1,074 | 1,091 | 1,137 | 1,216 | 1,355 | 1,387 |
| Profit before tax | 5,215 | 6,320 | 6,026 | 6,467 | 7,306 | 8,604 | 9,165 | 10,605 | 11,879 | 13,344 | 13,926 | 14,415 | 14,189 |
| Tax % | 24% | 31% | 31% | 31% | 28% | 30% | 26% | 25% | 25% | 24% | 26% | 26% | |
| Net Profit | 3,956 | 4,376 | 4,151 | 4,490 | 5,227 | 6,060 | 6,756 | 7,999 | 8,892 | 10,143 | 10,282 | 10,671 | 10,827 |
| EPS in Rs | 18.24 | 20.17 | 19.18 | 20.68 | 24.09 | 27.97 | 31.17 | 34.03 | 37.79 | 43.07 | 43.74 | 45.32 | 45.95 |
| Dividend Payout % | 71% | 74% | 83% | 82% | 83% | 78% | 80% | 119% | 90% | 91% | 96% | 117% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 10.62% | -5.14% | 8.17% | 16.41% | 15.94% | 11.49% | 18.40% | 11.16% | 14.07% | 1.37% | 3.78% |
| Change in YoY Net Profit Growth (%) | 0.00% | -15.76% | 13.31% | 8.25% | -0.48% | -4.45% | 6.91% | -7.23% | 2.90% | -12.70% | 2.41% |
Hindustan Unilever Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 10% |
| 3 Years: | 6% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 9% |
| 3 Years: | 5% |
| TTM: | 3% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 5% |
| 3 Years: | 1% |
| 1 Year: | -6% |
| Return on Equity | |
|---|---|
| 10 Years: | 29% |
| 5 Years: | 21% |
| 3 Years: | 20% |
| Last Year: | 21% |
Last Updated: September 4, 2025, 9:25 pm
Balance Sheet
Last Updated: November 9, 2025, 1:30 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 216 | 216 | 216 | 216 | 216 | 216 | 216 | 235 | 235 | 235 | 235 | 235 | 235 |
| Reserves | 3,321 | 3,811 | 6,357 | 6,528 | 7,065 | 7,651 | 8,013 | 47,439 | 48,826 | 50,069 | 50,983 | 49,167 | 48,481 |
| Borrowings | 46 | 43 | 177 | 277 | 0 | 99 | 0 | 0 | 1,043 | 1,219 | 1,484 | 1,648 | 1,775 |
| Other Liabilities | 10,171 | 10,359 | 8,043 | 8,685 | 10,581 | 10,663 | 11,924 | 21,066 | 20,402 | 21,554 | 25,787 | 28,813 | 31,543 |
| Total Liabilities | 13,754 | 14,430 | 14,793 | 15,706 | 17,862 | 18,629 | 20,153 | 68,740 | 70,506 | 73,077 | 78,489 | 79,863 | 82,034 |
| Fixed Assets | 2,746 | 2,821 | 3,258 | 4,419 | 4,528 | 4,715 | 5,479 | 51,443 | 51,473 | 52,678 | 53,744 | 54,335 | 58,126 |
| CWIP | 373 | 516 | 408 | 229 | 461 | 406 | 597 | 745 | 1,313 | 1,132 | 1,025 | 1,009 | 1,022 |
| Investments | 2,838 | 3,025 | 2,592 | 3,794 | 2,873 | 2,716 | 1,255 | 2,709 | 3,521 | 2,882 | 4,625 | 3,810 | 3,958 |
| Other Assets | 7,797 | 8,067 | 8,535 | 7,264 | 10,000 | 10,792 | 12,822 | 13,843 | 14,199 | 16,385 | 19,095 | 20,709 | 18,928 |
| Total Assets | 13,754 | 14,430 | 14,793 | 15,706 | 17,862 | 18,629 | 20,153 | 68,740 | 70,506 | 73,077 | 78,489 | 79,863 | 82,034 |
Below is a detailed analysis of the balance sheet data for Hindustan Unilever Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 235.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 235.00 Cr..
- For Reserves, as of Sep 2025, the value is 48,481.00 Cr.. The value appears to be declining and may need further review. It has decreased from 49,167.00 Cr. (Mar 2025) to 48,481.00 Cr., marking a decrease of 686.00 Cr..
- For Borrowings, as of Sep 2025, the value is 1,775.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1,648.00 Cr. (Mar 2025) to 1,775.00 Cr., marking an increase of 127.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 31,543.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 28,813.00 Cr. (Mar 2025) to 31,543.00 Cr., marking an increase of 2,730.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 82,034.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 79,863.00 Cr. (Mar 2025) to 82,034.00 Cr., marking an increase of 2,171.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 58,126.00 Cr.. The value appears strong and on an upward trend. It has increased from 54,335.00 Cr. (Mar 2025) to 58,126.00 Cr., marking an increase of 3,791.00 Cr..
- For CWIP, as of Sep 2025, the value is 1,022.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,009.00 Cr. (Mar 2025) to 1,022.00 Cr., marking an increase of 13.00 Cr..
- For Investments, as of Sep 2025, the value is 3,958.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,810.00 Cr. (Mar 2025) to 3,958.00 Cr., marking an increase of 148.00 Cr..
- For Other Assets, as of Sep 2025, the value is 18,928.00 Cr.. The value appears to be declining and may need further review. It has decreased from 20,709.00 Cr. (Mar 2025) to 18,928.00 Cr., marking a decrease of 1,781.00 Cr..
- For Total Assets, as of Sep 2025, the value is 82,034.00 Cr.. The value appears strong and on an upward trend. It has increased from 79,863.00 Cr. (Mar 2025) to 82,034.00 Cr., marking an increase of 2,171.00 Cr..
Notably, the Reserves (48,481.00 Cr.) exceed the Borrowings (1,775.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -42.00 | -38.00 | -172.00 | -271.00 | 7.00 | -91.00 | 9.00 | 11.00 | 11.00 | 13.00 | 13.00 | 13.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 13 | 12 | 14 | 12 | 13 | 17 | 11 | 14 | 16 | 19 | 18 | 22 |
| Inventory Days | 86 | 77 | 75 | 67 | 65 | 59 | 65 | 66 | 65 | 55 | 55 | 59 |
| Days Payable | 170 | 148 | 156 | 164 | 185 | 166 | 176 | 163 | 145 | 123 | 143 | 152 |
| Cash Conversion Cycle | -72 | -60 | -67 | -85 | -107 | -90 | -101 | -83 | -64 | -50 | -70 | -71 |
| Working Capital Days | -54 | -53 | -26 | -35 | -37 | -30 | -31 | -32 | -22 | -15 | -22 | -33 |
| ROCE % | 147% | 139% | 112% | 91% | 103% | 116% | 117% | 39% | 25% | 27% | 27% | 28% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Nifty 50 ETF | 16,489,465 | 2.21 | 4580.77 | 16,489,465 | 2025-04-22 17:01:36 | 0% |
| SBI BSE Sensex ETF | 11,802,512 | 2.62 | 3278.86 | 11,802,512 | 2025-04-22 17:01:36 | 0% |
| ICICI Prudential Value Discovery Fund | 5,658,246 | 3.13 | 1571.86 | 5,658,246 | 2025-04-22 17:01:36 | 0% |
| UTI Nifty 50 ETF | 4,782,594 | 2.21 | 1328.6 | 4,782,594 | 2025-04-22 17:01:36 | 0% |
| SBI Blue Chip Fund | 4,590,000 | 2.47 | 1275.1 | 4,590,000 | 2025-04-22 17:01:36 | 0% |
| UTI BSE Sensex ETF | 4,364,862 | 2.62 | 1212.6 | 4,364,862 | 2025-04-22 17:01:36 | 0% |
| ICICI Prudential Balanced Advantage Fund | 3,217,964 | 1.46 | 893.95 | 3,217,964 | 2025-04-22 17:01:36 | 0% |
| Nippon India ETF Nifty 50 BeES | 2,606,174 | 2.21 | 724 | 2,606,174 | 2025-04-22 09:14:30 | 0% |
| Kotak Flexicap Fund - Regular Plan | 2,600,000 | 1.36 | 722.28 | 2,600,000 | 2025-04-22 14:53:35 | 0% |
| Mirae Asset Large Cap Fund | 2,315,497 | 1.55 | 643.25 | 2,315,497 | 2025-04-22 17:01:36 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 45.32 | 43.74 | 43.07 | 37.79 | 34.03 |
| Diluted EPS (Rs.) | 45.32 | 43.74 | 43.07 | 37.79 | 34.03 |
| Cash EPS (Rs.) | 51.21 | 48.94 | 48.00 | 42.48 | 38.61 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 210.22 | 217.95 | 214.99 | 208.88 | 202.95 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 210.22 | 217.95 | 214.99 | 208.88 | 202.95 |
| Revenue From Operations / Share (Rs.) | 268.60 | 263.39 | 257.79 | 223.17 | 200.12 |
| PBDIT / Share (Rs.) | 67.52 | 65.85 | 62.39 | 55.81 | 51.22 |
| PBIT / Share (Rs.) | 61.76 | 60.67 | 57.55 | 51.17 | 46.65 |
| PBT / Share (Rs.) | 61.37 | 59.28 | 56.79 | 50.53 | 45.13 |
| Net Profit / Share (Rs.) | 45.44 | 43.77 | 43.17 | 37.84 | 34.04 |
| NP After MI And SOA / Share (Rs.) | 45.31 | 43.73 | 43.06 | 37.78 | 34.02 |
| PBDIT Margin (%) | 25.13 | 25.00 | 24.20 | 25.00 | 25.59 |
| PBIT Margin (%) | 22.99 | 23.03 | 22.32 | 22.92 | 23.30 |
| PBT Margin (%) | 22.84 | 22.50 | 22.03 | 22.64 | 22.55 |
| Net Profit Margin (%) | 16.91 | 16.61 | 16.74 | 16.95 | 17.00 |
| NP After MI And SOA Margin (%) | 16.87 | 16.60 | 16.70 | 16.92 | 17.00 |
| Return on Networth / Equity (%) | 21.55 | 20.06 | 20.11 | 18.09 | 16.77 |
| Return on Capital Employeed (%) | 22.91 | 21.72 | 22.14 | 20.29 | 19.01 |
| Return On Assets (%) | 13.33 | 13.09 | 13.84 | 12.59 | 11.62 |
| Asset Turnover Ratio (%) | 0.79 | 0.81 | 0.83 | 0.73 | 1.04 |
| Current Ratio (X) | 1.33 | 1.66 | 1.41 | 1.38 | 1.28 |
| Quick Ratio (X) | 1.07 | 1.34 | 1.06 | 1.01 | 0.95 |
| Inventory Turnover Ratio (X) | 4.61 | 4.66 | 4.73 | 4.25 | 4.86 |
| Dividend Payout Ratio (NP) (%) | 116.94 | 91.44 | 83.58 | 84.68 | 110.20 |
| Dividend Payout Ratio (CP) (%) | 103.74 | 81.77 | 75.14 | 75.41 | 97.15 |
| Earning Retention Ratio (%) | -16.94 | 8.56 | 16.42 | 15.32 | -10.20 |
| Cash Earning Retention Ratio (%) | -3.74 | 18.23 | 24.86 | 24.59 | 2.85 |
| Interest Coverage Ratio (X) | 40.17 | 46.33 | 128.61 | 123.73 | 102.87 |
| Interest Coverage Ratio (Post Tax) (X) | 27.26 | 31.78 | 90.55 | 85.25 | 71.42 |
| Enterprise Value (Cr.) | 523601.25 | 525697.75 | 596944.25 | 477659.75 | 566787.00 |
| EV / Net Operating Revenue (X) | 8.30 | 8.49 | 9.85 | 9.11 | 12.05 |
| EV / EBITDA (X) | 33.00 | 33.97 | 40.72 | 36.42 | 47.09 |
| MarketCap / Net Operating Revenue (X) | 8.41 | 8.61 | 9.93 | 9.18 | 12.15 |
| Retention Ratios (%) | -16.94 | 8.55 | 16.41 | 15.31 | -10.20 |
| Price / BV (X) | 10.75 | 10.41 | 11.95 | 9.81 | 11.98 |
| Price / Net Operating Revenue (X) | 8.41 | 8.61 | 9.93 | 9.18 | 12.15 |
| EarningsYield | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 |
After reviewing the key financial ratios for Hindustan Unilever Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 45.32. This value is within the healthy range. It has increased from 43.74 (Mar 24) to 45.32, marking an increase of 1.58.
- For Diluted EPS (Rs.), as of Mar 25, the value is 45.32. This value is within the healthy range. It has increased from 43.74 (Mar 24) to 45.32, marking an increase of 1.58.
- For Cash EPS (Rs.), as of Mar 25, the value is 51.21. This value is within the healthy range. It has increased from 48.94 (Mar 24) to 51.21, marking an increase of 2.27.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 210.22. It has decreased from 217.95 (Mar 24) to 210.22, marking a decrease of 7.73.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 210.22. It has decreased from 217.95 (Mar 24) to 210.22, marking a decrease of 7.73.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 268.60. It has increased from 263.39 (Mar 24) to 268.60, marking an increase of 5.21.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 67.52. This value is within the healthy range. It has increased from 65.85 (Mar 24) to 67.52, marking an increase of 1.67.
- For PBIT / Share (Rs.), as of Mar 25, the value is 61.76. This value is within the healthy range. It has increased from 60.67 (Mar 24) to 61.76, marking an increase of 1.09.
- For PBT / Share (Rs.), as of Mar 25, the value is 61.37. This value is within the healthy range. It has increased from 59.28 (Mar 24) to 61.37, marking an increase of 2.09.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 45.44. This value is within the healthy range. It has increased from 43.77 (Mar 24) to 45.44, marking an increase of 1.67.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 45.31. This value is within the healthy range. It has increased from 43.73 (Mar 24) to 45.31, marking an increase of 1.58.
- For PBDIT Margin (%), as of Mar 25, the value is 25.13. This value is within the healthy range. It has increased from 25.00 (Mar 24) to 25.13, marking an increase of 0.13.
- For PBIT Margin (%), as of Mar 25, the value is 22.99. This value exceeds the healthy maximum of 20. It has decreased from 23.03 (Mar 24) to 22.99, marking a decrease of 0.04.
- For PBT Margin (%), as of Mar 25, the value is 22.84. This value is within the healthy range. It has increased from 22.50 (Mar 24) to 22.84, marking an increase of 0.34.
- For Net Profit Margin (%), as of Mar 25, the value is 16.91. This value exceeds the healthy maximum of 10. It has increased from 16.61 (Mar 24) to 16.91, marking an increase of 0.30.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 16.87. This value is within the healthy range. It has increased from 16.60 (Mar 24) to 16.87, marking an increase of 0.27.
- For Return on Networth / Equity (%), as of Mar 25, the value is 21.55. This value is within the healthy range. It has increased from 20.06 (Mar 24) to 21.55, marking an increase of 1.49.
- For Return on Capital Employeed (%), as of Mar 25, the value is 22.91. This value is within the healthy range. It has increased from 21.72 (Mar 24) to 22.91, marking an increase of 1.19.
- For Return On Assets (%), as of Mar 25, the value is 13.33. This value is within the healthy range. It has increased from 13.09 (Mar 24) to 13.33, marking an increase of 0.24.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.79. It has decreased from 0.81 (Mar 24) to 0.79, marking a decrease of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 1.33. This value is below the healthy minimum of 1.5. It has decreased from 1.66 (Mar 24) to 1.33, marking a decrease of 0.33.
- For Quick Ratio (X), as of Mar 25, the value is 1.07. This value is within the healthy range. It has decreased from 1.34 (Mar 24) to 1.07, marking a decrease of 0.27.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.61. This value is within the healthy range. It has decreased from 4.66 (Mar 24) to 4.61, marking a decrease of 0.05.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 116.94. This value exceeds the healthy maximum of 50. It has increased from 91.44 (Mar 24) to 116.94, marking an increase of 25.50.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 103.74. This value exceeds the healthy maximum of 50. It has increased from 81.77 (Mar 24) to 103.74, marking an increase of 21.97.
- For Earning Retention Ratio (%), as of Mar 25, the value is -16.94. This value is below the healthy minimum of 40. It has decreased from 8.56 (Mar 24) to -16.94, marking a decrease of 25.50.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is -3.74. This value is below the healthy minimum of 40. It has decreased from 18.23 (Mar 24) to -3.74, marking a decrease of 21.97.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 40.17. This value is within the healthy range. It has decreased from 46.33 (Mar 24) to 40.17, marking a decrease of 6.16.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 27.26. This value is within the healthy range. It has decreased from 31.78 (Mar 24) to 27.26, marking a decrease of 4.52.
- For Enterprise Value (Cr.), as of Mar 25, the value is 523,601.25. It has decreased from 525,697.75 (Mar 24) to 523,601.25, marking a decrease of 2,096.50.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 8.30. This value exceeds the healthy maximum of 3. It has decreased from 8.49 (Mar 24) to 8.30, marking a decrease of 0.19.
- For EV / EBITDA (X), as of Mar 25, the value is 33.00. This value exceeds the healthy maximum of 15. It has decreased from 33.97 (Mar 24) to 33.00, marking a decrease of 0.97.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 8.41. This value exceeds the healthy maximum of 3. It has decreased from 8.61 (Mar 24) to 8.41, marking a decrease of 0.20.
- For Retention Ratios (%), as of Mar 25, the value is -16.94. This value is below the healthy minimum of 30. It has decreased from 8.55 (Mar 24) to -16.94, marking a decrease of 25.49.
- For Price / BV (X), as of Mar 25, the value is 10.75. This value exceeds the healthy maximum of 3. It has increased from 10.41 (Mar 24) to 10.75, marking an increase of 0.34.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 8.41. This value exceeds the healthy maximum of 3. It has decreased from 8.61 (Mar 24) to 8.41, marking a decrease of 0.20.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Hindustan Unilever Ltd:
- Net Profit Margin: 16.91%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 22.91% (Industry Average ROCE: 29.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 21.55% (Industry Average ROE: 22.42%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 27.26
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.07
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 53.5 (Industry average Stock P/E: 50.11)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 16.91%
FAQ
What is the intrinsic value of Hindustan Unilever Ltd?
Hindustan Unilever Ltd's intrinsic value (as of 10 November 2025) is 1866.76 which is 22.51% lower the current market price of 2,409.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 5,65,852 Cr. market cap, FY2025-2026 high/low of 2,780/2,136, reserves of ₹48,481 Cr, and liabilities of 82,034 Cr.
What is the Market Cap of Hindustan Unilever Ltd?
The Market Cap of Hindustan Unilever Ltd is 5,65,852 Cr..
What is the current Stock Price of Hindustan Unilever Ltd as on 10 November 2025?
The current stock price of Hindustan Unilever Ltd as on 10 November 2025 is 2,409.
What is the High / Low of Hindustan Unilever Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Hindustan Unilever Ltd stocks is 2,780/2,136.
What is the Stock P/E of Hindustan Unilever Ltd?
The Stock P/E of Hindustan Unilever Ltd is 53.5.
What is the Book Value of Hindustan Unilever Ltd?
The Book Value of Hindustan Unilever Ltd is 207.
What is the Dividend Yield of Hindustan Unilever Ltd?
The Dividend Yield of Hindustan Unilever Ltd is 1.79 %.
What is the ROCE of Hindustan Unilever Ltd?
The ROCE of Hindustan Unilever Ltd is 27.8 %.
What is the ROE of Hindustan Unilever Ltd?
The ROE of Hindustan Unilever Ltd is 20.7 %.
What is the Face Value of Hindustan Unilever Ltd?
The Face Value of Hindustan Unilever Ltd is 1.00.